Key Finding
Yangxue Qingnao Granules significantly reduced migraine frequency compared to placebo, conventional medications, and other Chinese patent medicines across 12 randomized controlled trials involving 767 patients.
If you suffer from migraines, you may be wondering whether traditional Chinese herbal medicine could help. A new research review published in the World Journal of Clinical Cases looked closely at a Chinese herbal formula called Yangxue Qingnao Granules (YXQN) to see how well it works for migraine relief.
Researchers analyzed 12 carefully selected clinical trials involving 767 migraine patients. They compared YXQN against a placebo (sugar pill), standard migraine medications, and other Chinese herbal medicines. The results were encouraging.
Patients taking YXQN experienced significantly fewer migraines compared to those taking a placebo or standard medications. The frequency of headaches dropped meaningfully across all comparison groups. When pitted against other Chinese herbal medicines, YXQN also came out ahead in reducing how long each headache lasted.
Where did YXQN fall short? Headache severity scores improved but did not reach statistical significance in any of the comparison groups, meaning the pain intensity reduction, while promising, wasn't conclusively proven. Headache duration results were also mixed when compared to placebo and standard drugs.
On the safety front, the news was reassuring. Only three cases of mild gastrointestinal side effects were reported across all studies, suggesting YXQN is generally well tolerated.
What does this mean for migraine sufferers? Chinese herbal medicine, particularly formulas like YXQN, may offer a meaningful reduction in how often migraines strike. While it may not replace your current treatment plan entirely, it could be a valuable complementary option worth discussing with your healthcare provider.
If you are curious about herbal medicine or acupuncture for migraine management, speak with a licensed and qualified Traditional Chinese Medicine practitioner who can tailor a treatment plan to your individual needs.
This systematic review and meta-analysis (World Journal of Clinical Cases) evaluated the efficacy and safety of Yangxue Qingnao Granules (YXQN), a standardized Chinese patent medicine, for migraine treatment. Twelve RCTs (n=767) were included, with comparisons against placebo, conventional pharmacotherapy, and other Chinese patent medicines. Methodological quality was assessed using ROB 2.0; data were pooled in Review Manager 5.4.
Key findings: YXQN significantly outperformed placebo (RR=0.29, 95%CI: 0.15–0.43), routine treatment (RR=0.18, 95%CI: 0.09–0.27), and other Chinese patent medicines (RR=0.27, 95%CI: 0.13–0.41) on overall efficacy. Headache frequency was significantly reduced across all comparison arms. YXQN demonstrated superior headache duration reduction versus other Chinese patent medicines (MD=-1.24, 95%CI: -1.70 to -0.77), though duration and severity outcomes showed no significant differences versus placebo or conventional drugs. Adverse events were limited to three mild gastrointestinal cases. Clinically, YXQN represents a well-tolerated adjunct option for migraine frequency reduction, though higher-quality RCTs are needed to clarify severity and duration outcomes.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Acupuncture reduces migraine symptoms in rat models primarily by suppressing CGRP, substance P, and 5-HT neurotransmitters, inhibiting microglial activation, and modulating the descending pain modulatory system to reduce neurogenic inflammation and central sensitization.
📌 A non-linear dose-response analysis found that 16 acupuncture sessions delivered three times per week over approximately two months produced the greatest reduction in migraine attack frequency, with diminishing benefits beyond this threshold.
📌 Cupping therapy was associated with an 83% higher likelihood of treatment success in migraine patients (RR 1.83, 95% CI: 1.52–2.21), with wet cupping demonstrating the strongest effect.